
Zoetis Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

I'm PortAI, I can summarize articles.
Zoetis Inc. stock rose 1.26% to $123.78 on Monday, underperforming compared to competitors Merck & Co. Inc. and IDEXX Laboratories Inc. Despite gains, Zoetis remains 30.23% below its 52-week high. Trading volume exceeded its 50-day average.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

